cathworks

CathWorks reported the completion of a $30 million Series D financing round. Proceeds from the financing will be used to expand commercialization of the company's FFRangio system. Read More →

CathWorks has received Japanese Ministry of Health, Labour and Welfare (MHLW) approval of The CathWorks FFRangio System, a non-invasive diagnostic technology that is used at the time of a routine angiography. Read More →

CathWorks today announced the approval of The CathWorks FFRangio™ System by the Japan’s Ministry of Health, Labour and Welfare (MHLW). The CathWorks FFRangio System is a non-invasive diagnostic technology that is used at the time of a routine angiography. The CathWorks... Read More →

CathWorks announced that its FFRangio System has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The FFRangio system demonstrated accuracy versus the invasive FFR wire in a blinded comparative study, FAST-FFR. The results of the FAST-FFR pivotal study were... Read More →

KFAR-SABA, Israel & ALISO VIEJO, Calif.–(BUSINESS WIRE)–CathWorks announced the completion of a $30 million Series C financing round led by Deerfield Management. Jim Corbett, CathWorks CEO, stated, “We are delighted to have such a notable investor leading this round and... Read More →